Immunomedics (IMMU) Reports Q1 Loss of $0.34

November 7, 2018 5:05 PM EST

Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.34), versus ($0.97) reported last year.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings